AIA Group Limited (1299.HK)
Hong Kong, HK
AIA Group Limited, together with its subsidiaries, provides life insurance based financial services in Hong Kong. The company offers life insurance, accident, and health insurance and savings plans; and employee benefits, credit life, and pension services to corporate clients. It is also involved in the distribution of investment and other financial services products. It sells its products through a network of agents and partners in Mainland China, Macau, Thailand, Singapore, Malaysia, Australia, Cambodia, Indonesia, Myanmar, New Zealand, the Philippines, South Korea, Sri Lanka, Taiwan, Brunei, Vietnam, and India. AIA Group Limited was founded in 1919 and is headquartered in Central, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.12% | -2.66% | -3.29% | -5.24% | +2.05% | +2.94% | +25.29% | +7.52% | -17.09% | +83.59% | +256.83% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 16 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+60.1% ★ Q4'25: +58.9% (vs Q4'23)
-
EPS growth Insurance - Life: +13.4%-4.8% Q4'25: +169.2% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Life: +31.7%-67.2% Q4'25: +0.9% (vs Q4'23)
-
EBIT margin Insurance - Life: +12.4%+25.0% ★ Q4'25: +27.7% (vs Q4'23)
-
ROIC Insurance - Life: +1.0%+12.5% ★ Q4'25: +29.4% (vs Q4'23)
-
Share dilution Insurance - Life: +0.4%-4.6% ★ Q4'25: -8.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×2.53× Q4'25: 1.09× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 12 Rev. Ana. 11 EPS Ana. |
Dec 2027 12 Rev. Ana. 11 EPS Ana. |
Dec 2028 10 Rev. Ana. 14 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
22.49B
est: 19.02B (+18.2%)
|
27.80B
est: 20.49B (+35.6%)
|
38.76B
est: 23.81B (+62.8%)
|
33.02B
est: 29.78B (+10.9%)
|
47.95B
est: 36.21B (+32.4%)
|
50.85B
est: 43.95B (+15.7%)
|
46.90B
est: 47.13B (-0.5%)
|
-24.96B
est: 42.53B (-158.7%)
|
20.03B
est: 2.69B (+645.0%)
|
20.36B
est: 29.75B (-31.6%)
|
32.58B
est: 22.23B (+46.6%)
|
24.37B
23.67B – 25.33B
+9.6% YoY
|
26.89B
25.63B – 28.77B
+10.3% YoY
|
29.88B
28.74B – 31.54B
+11.1% YoY
|
| EBITDA |
3.86B
est: 3.57B (+8.2%)
|
5.66B
est: 3.84B (+47.2%)
|
9.16B
est: 4.46B (+105.3%)
|
5.04B
est: 5.58B (-9.7%)
|
7.67B
est: 461.57M (+1,561.7%)
|
11.37B
est: 1.06B (+974.5%)
|
9.22B
est: 1.21B (+662.8%)
|
4.84B
est: 1.32B (+265.8%)
|
5.47B
est: 518.22M (+954.6%)
|
8.92B
est: 5.67B (+57.3%)
|
8.15B
est: 4.28B (+90.1%)
|
4.70B
4.56B – 4.88B
+9.6% YoY
|
5.18B
4.94B – 5.55B
+10.3% YoY
|
5.76B
5.54B – 6.08B
+11.1% YoY
|
| EBIT |
3.57B
est: 3.40B (+5.0%)
|
4.96B
est: 3.66B (+35.5%)
|
7.37B
est: 4.25B (+73.3%)
|
—
est: 5.32B (-100.0%)
|
7.33B
est: 500.67M (+1,364.2%)
|
7.56B
est: 1.07B (+609.5%)
|
8.83B
est: 1.22B (+625.2%)
|
4.45B
est: 1.33B (+233.9%)
|
5.05B
est: 498.46M (+912.9%)
|
8.45B
est: 5.46B (+54.8%)
|
8.15B
est: 4.12B (+97.7%)
|
4.52B
4.39B – 4.70B
+9.6% YoY
|
4.98B
4.75B – 5.33B
+10.3% YoY
|
5.54B
5.33B – 5.85B
+11.1% YoY
|
| Net Income |
2.69B
est: 3.00B (-10.3%)
|
4.16B
est: 3.40B (+22.3%)
|
6.12B
est: 4.98B (+23.0%)
|
2.92B
est: 4.02B (-27.4%)
|
5.98B
est: 370.65M (+1,513.1%)
|
5.78B
est: 896.63M (+544.5%)
|
7.43B
est: 1.02B (+625.5%)
|
3.33B
est: 989.00M (+236.8%)
|
3.76B
est: 618.37M (+508.7%)
|
6.84B
est: 771.47M (+786.1%)
|
6.24B
est: 7.11B (-12.2%)
|
7.71B
7.53B – 7.89B
+8.4% YoY
|
8.53B
8.07B – 8.98B
+10.6% YoY
|
9.36B
7.99B – 10.73B
+9.8% YoY
|
| SGA |
1.64B
est: 447.38M (+266.1%)
|
1.75B
est: 482.10M (+263.4%)
|
1.97B
est: 560.07M (+251.6%)
|
2.18B
est: 700.63M (+211.7%)
|
2.47B
est: 288.73M (+754.8%)
|
2.70B
est: 286.60M (+840.3%)
|
3.03B
est: 327.23M (+826.3%)
|
—
est: 358.22M (-100.0%)
|
—
est: 34.75M (-100.0%)
|
—
est: 380.28M (-100.0%)
|
—
est: 287.27M (-100.0%)
|
314.94M
305.87M – 327.39M
+9.6% YoY
|
347.49M
331.23M – 371.82M
+10.3% YoY
|
386.19M
371.41M – 407.64M
+11.1% YoY
|
| EPS |
0.23
est: 0.27 (-15.1%)
|
0.35
est: 0.31 (+13.8%)
|
0.51
est: 0.45 (+13.5%)
|
0.24
est: 0.36 (-33.9%)
|
0.50
est: 0.53 (-5.3%)
|
0.48
est: 0.44 (+8.1%)
|
0.62
est: 0.53 (+16.6%)
|
0.28
est: 0.26 (+8.0%)
|
0.33
est: 0.05 (+504.4%)
|
0.62
est: 0.61 (+2.4%)
|
0.59
est: 0.67 (-11.7%)
|
0.73
0.71 – 0.75
+8.8% YoY
|
0.82
0.76 – 0.85
+12.1% YoY
|
0.92
0.76 – 1.02
+12.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-13 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-12 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-11 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-08 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-06 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ATLAS CAPITAL ADVISORS LLC | 24.8K +24.8K (+100.0%) | 255.06M +255.1M (+100.0%) | 0.00% +0.000 pp | 0.03% +0.028 pp | HKD79.90 +0.0% | 1 qtrs NEW |
| 2 | ARISTOTLE CAPITAL MANAGEMENT, LLC | 6.18M +42.6K (+0.7%) | 63.39M +4.6M (+7.7%) | 0.06% +0.000 pp | 0.13% +0.013 pp | HKD83.38 -4.2% | 15 qtrs — |
| 3 | BOSTON COMMON ASSET MANAGEMENT, LLC | — -1.8M (-100.0%) | — -17.7M (-100.0%) | 0.00% -0.017 pp | 0.00% -0.494 pp | HKD— | 12 qtrs SOLD |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yuan Siong Lee | Group Chief Executive, President & Executive Director | 59M | male |
| Biswa Prakash Misra | Group Chief Technology Officer & Life Operations Officer | — | male |
| Garth Brian Jones | Group Chief Financial Officer | — | male |
| Mark Konyn | Group Chief Investment Officer | — | male |
| Mitchell David New | Group General Counsel | — | male |
| Andrew Leung | Head of External Manager Strategies | — | male |
| Sami Taipalus | Group Chief Investor Relations Officer | — | male |
| Stuart Anthony Spencer | Group Chief Marketing Officer | — | male |
| Wing-Shing Chan | Regional Chief Executive & Group Chief Distribution Officer | — | male |
| Pek-San Ang | Group Chief Human Resources Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1299.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
